Two-drug approach could offer hope to ovarian cancer patients
A clinical trial combining two cancer therapies has shown promising results in patients with low grade serous ovarian cancer...
by Jen Willows
A clinical trial combining two cancer therapies has shown promising results in patients with low grade serous ovarian cancer...
by Jen Willows
Offering healthy people genetic screening could provide clinically important information in over 15 percent of cases...
BRCA2 mutations may be implicated in infertility, as well as increasing cancer risk, according to new research...
by Professor Anneke Lucassen and 1 others
Direct-to-consumer genomic testing is a thriving market – for example by June 2020, 23andMe had sold over a quarter of a million testing kits in the UK...
New research suggests mutations in multiple DNA repair genes can determine how well ovarian cancer patients will respond to the PARP inhibitor, rucaparib...
by Hannah Flynn
Cancer treatment olaparib has been shown to extend the life of relapsed ovarian cancer patients with mutations in BRCA1 and BRCA2, by nearly 13 months, when used as a maintenance therapy...
The three-dimensional structure of the human endometrium has been discovered, which could lead to greater insights into infertility, embryo implantation, and endometrium-related diseases...
A new scanning technique has the potential to replace tissue biopsies for complicated ovarian cancer patients...
Women who have received fertility treatment are not at increased risk of ovarian cancer, according to a new study...
A blood test already used to diagnose ovarian cancer is far more predictive than originally thought and may also diagnose other types of cancer...
BioNews, published by the Progress Educational Trust (PET), provides news and comment on genetics, assisted conception, embryo/stem cell research and related areas.